March 18, 2011
San Jose, CA - Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and [...]
Sage Bionetworks Announces Cancer Partnership with AstraZeneca
March 18, 2011
SEATTLE - Sage Bionetworks and AstraZeneca have initiated a collaboration to make new insights into certain cancers using advanced computational models of disease genetics. This deeper understanding of cancer will potentially help better match patients with appropriate treatments and might one day lead to new cancer therapeutics. The partnership will combine Sage Bionetworks’ expertise in [...]
RainDance Technologies Launches Two Comprehensive Genetic Screening Research Tools
March 18, 2011
VANCOUVER, British Columbia - RainDance Technologies, Inc., today announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels. Developed in collaboration with Emory University and Greenwood Genetic Center, the two comprehensive panels enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder [...]
BD Completes Acquisition of Accuri Cytometers, Inc.
March 18, 2011
Franklin Lakes, NJ - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers. The acquisition expands BD’s presence into the emerging affordable personal flow cytometer space, and [...]
March 17, 2011
GE Healthcare has extended its WAVE Bioreactor platform with the launch of the WAVEPOD™ II Integrated Controller, the pHOPT optical pH sensor, and UNICORN™ DAQ 1.0 software. All specifically designed to improve monitoring and control of cell culture conditions in WAVE Bioreactor Systems, and forming part of GE Healthcare’s ReadyToProcess™ platform of ready-to-use products for [...]
Sigma® Life Science Launches Suite of Knockout Rats to Model Parkinson’s Disease
March 17, 2011
St. Louis, MO. - Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich® (Nasdaq:SIAL), announced that its SAGE Labs initiative has created a suite of knockout rat models of Parkinson's disease in collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF). Developed using the proprietary SAGEspeed™ model creation process, [...]
Pall GeneDisc® System First AOAC Validated Test for Non-O157 STEC in Food
March 17, 2011
PORT WASHINGTON, N.Y. - Pall Corporation (NYSE: PLL) announced today that its GeneDisc Rapid Microbiology system has been validated by the AOAC Research Institute for detection of non-O157 STEC in meat. This validation from one of the world's leading standards organizations is expected to enable more effective monitoring of the food supply for pathogenic E. [...]
March 17, 2011
Menlo Park, Calif. and Bethpage, NY - SRI International and the Applied Science Foundation for Homeland Security have signed a strategic alliance partner agreement to foster collaboration relating to the development, testing, and fielding of technology designed to meet the needs of first responders at the federal, state, and local levels. The agreement between the [...]
PharmaDiagnostics Announces Three New Coupling Methods for its SoPRano™ Label-Free Platform
March 17, 2011
Brussels - PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today the launch of three new methods for coupling proteins to the gold nanoparticles used with PharmaDiagnostics’ SoPRanoTM technology. The new coupling methods will greatly expand the technology’s applicability in the key drug [...]
BioNanomatrix Secures $23.3 Million in Series B Financing
March 17, 2011
PHILADELPHIA - BioNanomatrix, Inc., a developer of nanoscale, single-molecule imaging and analysis platforms designed to dramatically reduce the time and cost needed to analyze the genome, has closed a $23.3-million Series B round of equity financing. Domain Associates, based in Princeton, N.J., and San Diego, Calif., led the round, with new investor Gund Investment Corporation [...]
